Introduction
The success of cancer gene therapy depends on development of vectors that exhibit tumor specificity, efficiency and safety. Cationic liposome-mediated gene transfection has been utilized in in vitro and in vivo experiments. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Cationic liposomal transfection has the advantage of easy preparation and lack of severe side-effects. In comparison with viral vectors, liposomal vectors are free from pathogenicity, activation of oncogenes and immune responses such as against viral proteins. [12] [13] [14] [15] [16] [17] [18] [19] However, the transfection efficiency of liposomal vectors is insufficient as compared with viral vectors and requires improvement. To solve this problem, we conducted experiments using novel cationic multilamellar vesicle liposomes composed of N-(␣-trimethylammonioacetyl)-didodecyl-D-glutamate chloride (TMAG), dilauroyl-phosphatidylcholine (DLPC), and dioleoyl phosphatidyl-ethanolamine (DOPE) (1:2:2, molar ratio) containing a strong expression promoter-enhancer system CAG and transcriptional activator high mobility group 1,2 (HMG-1,2) non-histone chromatin proteins. 7, 20, 21 We encapsulated endotoxin-free plasmid DNA, because endotoxins are known to hinder in vivo transfection, cause endotoxic shock syndrome and activate complement cas-cade. 22 We constructed the plasmids pcagluc and pcagTNF-␣ incorporating beetle luciferase and the human tumor necrosis factor-␣ (TNF-␣) gene, respectively, with a modified chicken ␤-actin promoter, and the immediate-early enhancer of cytomegalovirus. We also included HMG-1,2, a major component of chromatin that enhances the expression of transfected reporter genes by approximately two-fold. [23] [24] [25] Liposomes containing the TNF-␣ expression plasmid were administered with recombinant interferon-␥ (INF-␥) protein to treat intraperitoneal tumors in nude mice. TNF-␣ exhibits strong antitumoral effects against certain tumor cells by induction of apoptosis and this effect is enhanced by combination treatment with INF-␥. [26] [27] [28] [29] We initially determined the optimal ratios of plasmid DNA and HMG-1,2 protein entrapped in the cationic liposomes in in vitro studies. The most effective dose of liposomes was determined using the luciferase expression gene in tumor-bearing nude mice. Finally, we investigated the antitumor activity of cationic liposome-mediated gene therapy combined with INF-␥ administration in in vivo survival experiments.
Results

Optimal amount of DNA entrapped in cationic liposomes
The data in Figure 1 compare the transfection efficiency of cationic liposomes relative to the amount of DNA. MCF-7 cells (3 × 10 3 per well) were incubated for 24 h and then . When 300 g of DNA was encapsulated, the highest activity was obtained at 5.12 × 10 −8 mol/ml of liposomal concentration. Transfection efficiency increased until 300 g of the pcaglacZ was entrapped, whereas, it decreased at 400 g of DNA.
Optimal ratio of HMG-1,2 to DNA entrapped in cationic liposomes Figure 2 shows the liposomal transfection activity associated with the ratio of the HMG-1,2 to 300 g of pcaglacZ.
Twenty-four hours after MCF-7 cells (3 × 10 3 per well) were cultured, they were treated with the liposomes containing 300 g of DNA and the indicated amount of HMG-1,2 for 3 h. Each liposomal concentration ranged from 2.00 × 10 observed with encapsulation of 96 g of HMG-1,2 and 300 g of the pcaglacZ.
Optimal concentration of liposomes administered intraperitoneally to tumor bearing nude mice After the inoculation of 7.5 × 10 6 MCF-7 cells on day 0, various concentrations of liposomes (1.5 ml) composed of 10 mol lipid mixture, 300 g pcagluc and 96 g HMG-1,2 were injected intraperitoneally in nude mice on days 7, 14 and 21. On day 23, mice were killed and tumor tissues were removed and homogenised using a micromixer. The homogenate was assayed for luciferase activity and protein concentration. Figure 3 shows that transfection of tumor tissues was highest when 2.5 × 10 −7 mol/ml of liposomes was administered.
The same concentration of liposomes was administered intraperitoneally to non-tumor-bearing nude mice on days 7, 14 and 21, and the luciferase activity of homogenates of normal tissues (brain, lung, heart, diaphragm, liver, pancreas, spleen, kidney, uterus, ovary, bladder, peritoneum, intestine, mesentery) was determined on day 23 (Figure 4) . In tumor tissues, 5204 ± 1416 RLU/g protein per second of luciferase activity was found, however almost no luciferase activity was detected in the homogenates of all normal tissues examined after administration of both the pcagluc and the pcaglucR entrapped in liposomes.
Combination treatment of encapsulated pcagTNF-␣ in cationic liposomes and recombinant INF-␥ Either 4000 U of INF-␥ (1.0 ml) or normal saline (NS) (1.0 ml) was injected intraperitoneally on days 6, 13 and −7 mol/ml, 1.5 ml) composed of 10 mol of cationic lipid film, 300 g of either the pcagTNF-␣ or the pcagTNF-␣R and 96 g of HMG-1,2 was also administered to the nude mice intraperitoneally. The Kaplan-Meier survival curves show the therapeutic effects of the treatment regimens ( Figure 5 ). The results demonstrate that administration of cationic liposomes containing the TNF-␣ gene in combination with INF-␥ is most effective with a mean survival of 72.4 days (P Ͻ 0.001).
Discussion
In attempting to develop gene therapy for human cancer, particularly in the treatment of disseminated tumors, it is important to utilize a tumor-selective vector. In our previous work, we reported that pancreatic tumors in an experimental animal model were selectively transfected with exogenous genes using positively charged multilamellar vesicle liposomes composed of TMAG/ DLPC/DOPE (1:2:2; molar ratio). 30, 31 However, this cationic liposomal transfection was inefficient for clinical applicability. To address this issue, we incorporated the transcriptional activator HMG-1,2 protein with plasmid DNA containing the CAG promoter in the cationic liposomal vesicles. Inclusion of the HMG-1,2 protein resulted in about a two-fold increase in expression of the transgene in tumor cells, while there was no apparent transgene expression in the normal tissues tested (Figures 2 and 4) . HMG-1,2 protein is the most abundant and ubiquitous low molecular weight non-histone nuclear protein (MW approximately 28 000). 20 Several experiments have indicated that HMG-1,2 has transcriptional activation potential and enhances gene expression without dependence on the type of promoter or transgene. 25 In the present study, using cationic liposomes combined with HMG-1,2, we examined the tumoricidal activity of
Figure 5 Survival study of mice bearing peritoneal breast cancer xenografts. MCF-7 cells were injected to the nude mice intraperitoneally on day 0 (black arrow). On day 6, 13 and 20, mice were given intraperitoneal administration of either 4000 U of INF-␥ (1.0 ml) (b, ᭡) or NS (1.0 ml) (२, ȣ).
On day 7, 14 and 21, 2.5 × 10 −7 mol/ml of the liposomes (1.5 ml) constructed with 10 mol of cationic lipid mixture including either 300 g of the pcagTNF-␣ (b, ᮀ) or the pcagTNF-␣R (᭡, ȣ) and 96 g of the HMG-1,2 protein were administered in the same way (grey arrows). Values are the mean of eight or nine replicate determinations.
the TNF-␣ c-DNA as a suicidal gene. TNF-␣ possesses a wide range of biological activities. [26] [27] [28] [29] The induction of apoptosis by TNF-␣ is advantageous for cancer treatment. In survival experiments, the control group survived for 36.1 days (mean), while the group treated with endogenous TNF-␣/NS showed a 1.3-fold longer survival period (46 ± 4 days: mean ± s.e.) ( Figure 5 ). The intraperitoneal MCF-7 tumors invaded the uterus, urinary duct and bladder, and most of tumor-bearing mice died of acute renal failure following urinary obstruction. The activity of TNF-␣ is known to be increased by hyperthermia, mitomycin-C, cycloheximide, actinomycin-D and cis-diamminedichloroplatinum and INF-␥. 29, [32] [33] [34] Therefore we have tested the synergistic effects of administering recombinant INF-␥ in a disseminated intraperitoneal breast tumor in nude mice. We have achieved a two-fold increase in survival for the endogenous TNF-␣/exogenous INF-␥ administered group (72 ± 3 days: mean ± s.e.) as compared with the control group ( Figure 5) . At a preliminary experiment, we also observed that at day 30 all of six full treatment mice had almost no lesion in the peritoneal cavity, but that more than four tumor nodules invaded at the uterus, urinary duct and bladder of five control mice. Their size varied from 2 to 11 mm in diameter.
In this study, we encapsulated LPS-free plasmid in the cationic liposomes to avoid the unexpected induction of TNF-␣, the occurrence of endotoxic shock and to obtain a higher transfection efficiency. 22 For the treatment of TNF-␣-resistant tumors and for broader specificity of therapy, as well as safety, we are now investigating an approach for in vivo gene therapy using the deoxycytidine kinase gene inserted downstream of radiosensitive Egr-1 promoter controlled by a radioisotope entrapped in this cationic liposome. 35 Expression of deoxycytidine kinase in tumors will be exploited for treatment with cytosine arabinoside. 36 In the previous experiment, the radioisotopes Tc-99m, I-131 and Ga-67-citrate were demonstrated as Egr-1 activators and for their potential to accumulate in tumors. 37 In conclusion, the cationic liposome-mediated gene transfection represents an efficient and specific approach for cancer gene therapy.
Materials and methods
Plasmid constructs
Plasmids pcagluc, pcaglucR, pcagTNF-␣, pcagTNF-␣R were constructed from the pcaggs plasmid. 21 The SacI-BamHI fragment of the luciferase gene from the pGL2-cassette vector (Promega, Madison, WI, USA) was introduced into the SacI-BamHI segment of the pBluescriptII SK+ (Stratagene, La Jolla, CA, USA) that includes T3 and T7 promoters. The XhoI-XhoI fragments of the abovementioned construction including the forward luciferase gene and the reverse orientation luciferase gene were inserted into the XhoI-XhoI region of pcaggs, resulting in pcagluc and pcaglucR, respectively (Figure 6a) .
The KpnI-HpaI segment of plasmid pE425-TNF that includes the human TNF-␣ gene was cleaved and filled in by T4 DNA polymerase. After inserting SalI sites, the SalISalI fragments containing the TNF-␣ gene in the forward and reverse orientations were inserted in place of the XhoI- XhoI region of the pcaggs, resulting in pcagTNF-␣ and pcagTNF-␣R, respectively (Figure 6b) .
Plasmid pcaglacZ contains the ␤-galactosidase gene of E. coli, the modified chicken ␤-actin promoter, and the cytomegalovirus immediate-early enhancer. 21 Each plasmid was treated with endotoxin removal buffer (Qiagen, Hilden, Germany).
Tumor line
Human MCF-7 breast cancer cells (ATCC, Washington, DC, USA) were cultured in Eagle's MEM medium with phenol red (Gibco, Grand Island, NY, USA) and 10 g/ml insulin (Sigma, St Louis, MO, USA) supplemented with 10% heat-inactivated fetal bovine serum (Intergen, Purchase, NY, USA). 38 Cells were maintained at 37°C in a 5% CO 2 /95% air-humidified atmosphere.
Animals and xenografts
Virus-free, 5-week-old Swiss athymic nude mice (BALB/cA Jcl nu/nu homozygous; Clea Japan, Tokyo, Japan) were maintained on a ␥-ray sterile standard mouse food of pellets and distilled water. Animals were kept in a pathogen-free environment.
The mice were implanted with 17␤-estradiol pellets (60-day release, 0.72 mg per pellet) (Innovative Research of America, Sarasota, FL, USA) 2 days before and 58 days after inoculation of tumor cells. 39 At the start of each experiment, 1.0 ml of phosphate-buffered saline (PBS) containing gently trypsinized 7.5 × 10 6 MCF-7 cells were injected intraperitoneally into each nude mouse.
Liposome preparation
Ten micromoles of the lipid mixture (TMAG (Sogo Pharmacochemical, Tokyo, Japan):DLPC (Sigma):DOPE (Sigma) = 1:2:2; molar ratio) in 1 ml of chloroform solvent was introduced into a 10 ml pear shaped flask. This flask was attached to a rotary evaporator, evacuated and rotated at about 2.5 g in a thermostatically controlled water bath at 37°C under a stream of argon gas. The dry lipid film deposited on the walls of the flask was subjected to high vacuum for 2 h. The lipid film was hydrated in 300 l of balanced saline solution (BSS) with a dose of both plasmid DNA and HMG-1,2 and shaken by vortex mixer for 3 min at 37°C until a homogeneous milky white suspension without visible particles was obtained. 40 ␤-Galactosidase assay Forty-eight hours after transfection, the medium was aspirated from each well of 96-well plates. The cells were washed three times with PBS. Cell lysates were obtained by the addition of 50 l of cell lysis reagent (Promega) and incubated for 15 min at room temperature. The lysates were transferred to microcentrifuge tubes. After centrifugation at top speed for 2 min at 4°C, 25 l of supernatant was transferred to each well of fresh 96-well plates, and 25 l of o-nitrophenyl-␤-D-galactopyranoside (ONPG) solution (120 mm Na 2 HPO 4 , 80 mm NaH 2 PO 4 , 2 mm MgCl 2 , 100 mm ␤-mercaptoethanol, 1.33 mg/ml ONPG (Wako Pure Chemical Industries, Osaka, Japan) was added. After 30 min, the reaction was stopped by adding 50 l of 1 m Na 2 CO 3 and each plate was read on a microtiter plate reader at a wavelength of 420 nm. 41 For analysis of total protein content of each tissue, 10 l of the supernatant was assayed by the bicinchoninic acid (BCA) method. 42 Luciferase assay Cells and tissues were homogenized in cell lysis reagent (Promega) containing 1% Triton-X 100 and protease inhibitor and incubated for 15 min at room temperature. After centrifugation, 20 l of the supernatant was mixed with 100 l of luciferase assay reagent (Promega) containing beetle luciferin. Emission of light was measured with a luminometer (lumat LB9501; Berthold Designs, Berlin, Germany; delay time, 1.5 s; integrated time, 15 s). 43 For analysis of the total protein content, 10 l of the supernatant was assayed with the BCA method.
Statistical analysis
Overall survival was defined as the period between the inoculation of MCF-7 cells and death. The Cox proportional hazards regression model was used to evaluate the strength of the associations between administration of liposome and death. Kaplan-Meier survival curves were constructed for the administration of (1) liposomes that express TNF-␣ (LET) and INF-␥; (2) LET and NS; (3) liposomes that contained the TNF-␣ gene in reverse orientation (LUET) and INF-␥; and (4) LUET and NS. The Kaplan-Meier curves were examined using the log-rank test. Differences were considered significant when the probability values obtained from the statistical tests were 0.05 or less. Computer software StatView (Abacus Concepts, Berkeley, CA, USA) was used for data analysis.
